MAPT and Alzheimer disease: We assessed changes over a period of up to 14 years in AD hallmark CSF measures: ratio of ß-amyloid (Aß) 1-42 to Aß1-40, total tau (t-tau), and phosphorylated tau-181 (p-tau).